TickerFacts.

Theravance Biopharma, Inc. (TBPH): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2018-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$3.17M
Year ended 2018-12-31
+1.9%
3-year compound annual growth
+3.6%
5-year compound annual growth
$4.03M2012-12-31: $3.25M2013-12-31: $2.65M2014-12-31: $3.27M2015-12-31: $2.99M2016-12-31: $3.12M2017-12-31: $4.03M2018-12-31: $3.17M$3.17M
2012-12-31 Depreciation & Amortization (USD) 2018-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2018-12-31$3.17M-21.4%2019-02-28, From 2018-01-01
2017-12-31$4.03M+29.1%2019-02-28, From 2017-01-01
2016-12-31$3.12M+4.3%2019-02-28, From 2016-01-01
2015-12-31$2.99M-8.7%2018-02-28, From 2015-01-01
2014-12-31$3.27M+23.4%2017-03-01, From 2014-01-01
2013-12-31$2.65M-18.4%2016-03-11, From 2013-01-01
2012-12-31$3.25Mn/a2015-03-13, From 2012-01-01